Company: ALGN
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001097149-25-000034
Chunk: 147

Company: ALIGN TECHNOLOGY INC
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 8
Chunk 147
---
 Operating Metrics

We measure our performance against the foregoing strategic priorities by the achievement of key financial and operating metrics. For the three months ended March 31, 2025, our business operations reflect the following:

•Revenues of $979 million, a decrease of 1.8% year-over-year;

•Clear Aligner revenues of $797 million, a decrease of 2.5% year-over-year; 

•Clear Aligner case volume increased 6.2% year-over-year and Clear Aligner case volume for teens and growing patients increased from 199.2 thousand shipments to 225.8 thousand or 13.3% year-over-year; 

•Imaging Systems and computer-aided design and computer-aided manufacturing (“CAD/CAM”) Services revenues of $182 million, an increase of 1.2% year-over-year;

•Income from operations of $131 million and operating margin of 13.4%;

•Effective tax rate of 33.6%;

•Net income of $93 million with diluted net income per share of $1.27;

•Cash and cash equivalents of $873 million as of March 31, 2025;

•Cash provided by operating activities of $53 million;

•Capital expenditures of $25 million, primarily related to investments in our manufacturing capacity and facilities; and

•Number of employees was 21,200 as of March 31, 2025, a decrease of 2.2% year-over-year. 

Other Statistical Data and Trends

•As of March 31, 2025, approximately 20 million people worldwide have been treated with our Invisalign system. Management measures these results by comparing to the millions of people who can benefit from straighter teeth and uses this data to target opportunities to expand the market for orthodontics by educating consumers about the benefits of straighter teeth using the Invisalign system. 

•For the first quarter of 2025, the total number of Invisalign trained doctors cases were shipped to (doctor submitters) was 85.3 thousand compared to 83.5 thousand in first quarter of 2024, a 2.1% increase. 

•The total utilization rate in the first quarter of 2025 increased to 7.5 cases per doctor compared to 7.2 in the first quarter of 2024. This increase was primarily driven by improved utilization in our international markets. 

•The clear align